What is the address of SATRE ET SOINS?

The registered office of SATRE ET SOINS is located at Rue Roger de Keyser(FOR) 129, 6464 Chimay.

Is SATRE ET SOINS still active?

Yes. According to the CBE (31 October 2026) SATRE ET SOINS is active, legal situation “Normale toestand”, started on 7 January 2014.

Is SATRE ET SOINS registered on Peppol?

No, SATRE ET SOINS is currently not registered on the Peppol network.

What is the enterprise number of SATRE ET SOINS?

The enterprise number of SATRE ET SOINS is BE0543865736.

When was SATRE ET SOINS founded?

SATRE ET SOINS was founded on 7 January 2014.

Who are the directors of SATRE ET SOINS?

According to the 2025 annual accounts, the directors of SATRE ET SOINS are: ISABELLE SATRE.

Is SATRE ET SOINS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 January 2014; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SATRE ET SOINS make in 2025?

SATRE ET SOINS posted a profit after taxes of € 5,570 in financial year 2025.

What is the revenue of SATRE ET SOINS?

As a small company, SATRE ET SOINS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 26,799.

SATRE ET SOINS (Private Limited) - Chimay - BE0543865736

Dossier SATRE ET SOINS, printed on 31 October 2026 from databakkes.be/en/0543865736/satre-et-soins. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

SATRE ET SOINS from Chimay, company number BE0543865736, closed financial year 2025 with a result of € 5,570 after tax. For that financial year SATRE ET SOINS recorded a gross margin of € 26,799 and equity of € 49,658. Compared with financial year 2024, the result moved from € 11,001 to € 5,570. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Healthy

€ 49,658

▼ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 5,570

▼ 49% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 33,724

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 8,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 22,990

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 29,020

▼ 29% vs 2024

€ 16,258 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 14,874

▲ 51% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,773

▲ 6% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 22,112 Gross margin 2023: € 22,112 First fiscal year in the series	€ 27,679 Gross margin 2024: € 27,679 ▲ 25% vs 2023 (€ 22,112) Favourable step	€ 26,799 Gross margin 2025: € 26,799 ▼ 3% vs 2024 (€ 27,679) Unfavourable step	▼ 3%
Profit after taxes	€ -1,148 Profit after taxes 2023: € -1,148 First fiscal year in the series	€ 11,001 Profit after taxes 2024: € 11,001 ▲ € 12,150 vs 2023 (€ -1,148) Favourable step	€ 5,570 Profit after taxes 2025: € 5,570 ▼ 49% vs 2024 (€ 11,001) Unfavourable step	▼ 49%
Equity	€ 48,588 Equity 2023: € 48,588 First fiscal year in the series	€ 52,089 Equity 2024: € 52,089 ▲ 7% vs 2023 (€ 48,588) Favourable step	€ 49,658 Equity 2025: € 49,658 ▼ 5% vs 2024 (€ 52,089) Unfavourable step	▼ 5%
Total debts	€ 67,688 Total debts 2023: € 67,688 First fiscal year in the series	€ 65,106 Total debts 2024: € 65,106 ▼ 4% vs 2023 (€ 67,688) Favourable step	€ 59,267 Total debts 2025: € 59,267 ▼ 9% vs 2024 (€ 65,106) Favourable step	▼ 9%
Cash	€ 34,539 Cash 2023: € 34,539 First fiscal year in the series	€ 31,348 Cash 2024: € 31,348 ▼ 9% vs 2023 (€ 34,539) Unfavourable step	€ 33,724 Cash 2025: € 33,724 ▲ 8% vs 2024 (€ 31,348) Favourable step	▲ 8%
Retained profit	€ 47,588 Retained profit 2023: € 47,588 First fiscal year in the series	€ 51,089 Retained profit 2024: € 51,089 ▲ 7% vs 2023 (€ 47,588) Favourable step	€ 48,658 Retained profit 2025: € 48,658 ▼ 5% vs 2024 (€ 51,089) Unfavourable step	▼ 5%
Dividend	€ 5,000 Dividend 2023: € 5,000 First fiscal year in the series	€ 7,500 Dividend 2024: € 7,500 ▲ 50% vs 2023 (€ 5,000) Unchanged	€ 8,000 Dividend 2025: € 8,000 ▲ 7% vs 2024 (€ 7,500) Unchanged	▲ 7%
Bank debt	€ 42,704 Bank debt 2023: € 42,704 First fiscal year in the series	€ 40,784 Bank debt 2024: € 40,784 ▼ 4% vs 2023 (€ 42,704) Favourable step	€ 29,020 Bank debt 2025: € 29,020 ▼ 29% vs 2024 (€ 40,784) Favourable step	▼ 29%
Balance sheet total	€ 116,276 Balance sheet total 2023: € 116,276 First fiscal year in the series	€ 117,194 Balance sheet total 2024: € 117,194 ▲ 1% vs 2023 (€ 116,276) Unchanged	€ 108,925 Balance sheet total 2025: € 108,925 ▼ 7% vs 2024 (€ 117,194) Unchanged	▼ 7%

Key figures of SATRE ET SOINS, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SATRE ET SOINS?

What happened at SATRE ET SOINS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 5,570 (▼ 49% vs 2024). Source: NBB ↗
Jan 7, 2014 New establishment in Chimay. KBO
Jan 7, 2014 Start of the company according to the CBE. KBO

In short

From € 1,148 loss in 2023 to € 5,570 profit in 2025.

Paid € 11,253 in corporate taxes since 2023.

Best year ever: 2024, with € 11,001 profit.

Paid out € 20,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

ISABELLE SATRE

SATRE ET SOINS

Behind SATRE ET SOINS is ISABELLE SATRE.

Directors

According to the 2025 annual accounts

ISABELLE SATRE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Roger de Keyser(FOR) 129

6464 Chimay

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0543.865.736
VAT number: BE 0543.865.736
Registered office: Rue Roger de Keyser(FOR) 129, 6464 Chimay
Names & denominations: SATRE ET SOINS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 January 2014
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗